suprefact depot 3-months
sanofi - aventis israel ltd - buserelin acetate - rods for implant - buserelin acetate 9.9 mg - buserelin - buserelin - treatment of advanced hormone dependent prostatic carcinoma. however not after bilateral orchiectomy ( no further reduction of testosterone level by buserelin to be expected).
suprefact 5.5mg/5.5ml solution for injection vials
neon healthcare ltd - buserelin acetate - solution for injection - 1mg/1ml
suprefact 1 mg/ml solution for injection
sanofi-aventis ireland limited t/a sanofi - buserelin - solution for injection - 1 milligram(s)/millilitre - gonadotropin releasing hormone analogues; buserelin
suprefact nasal spray solution
sanofi malta limited level2, fort business centre, mriehel bypass, birkirkara, malta - buserelin - nasal spray, solution - buserelin 100 µg - endocrine therapy
suprefact 100micrograms/dose nasal spray
neon healthcare ltd - buserelin acetate - spray - 100microgram/1dose
suprefact 100 mcg/dose nasal spray solution
sanofi-aventis ireland limited t/a sanofi - buserelin acetate - nasal spray solution - 100 mcg/dose - gonadotropin releasing hormone analogues
suprefact
sanofi-aventis new zealand limited - buserelin acetate 1.05 mg/ml equivalent to 1 mg/ml buscerelin - solution for injection - 1 mg/ml - active: buserelin acetate 1.05 mg/ml equivalent to 1 mg/ml buscerelin excipient: benzyl alcohol monobasic sodium phosphate dihydrate sodium chloride sodium hydroxide water for injection - for the treatment of endometriosis not primarily requiring surgical treatment. pituitary desensitisation in preparation for ovulation induction regimens using gonadotrophins.
suprefact solution
cheplapharm arzneimittel gmbh - buserelin (buserelin acetate) - solution - 100mcg - buserelin (buserelin acetate) 100mcg - antineoplastic agents
suprefact solution
cheplapharm arzneimittel gmbh - buserelin (buserelin acetate) - solution - 1mg - buserelin (buserelin acetate) 1mg - antineoplastic agents
suprefact depot 2 months implant
cheplapharm arzneimittel gmbh - buserelin (buserelin acetate) - implant - 6.3mg - buserelin (buserelin acetate) 6.3mg - antineoplastic agents